European drugmakers that are focused on building portfolios of new medicines have gotten a nod from analysts at Goldman Sachs Group Inc.
Goldman Sachs Says Buy European Pharma Stocks Touting Innovation
30. May 2024 ACEST 13:19
Save for later
Latest
Der er ikke flere artikler i listen